Grantham, Mayo, Van Otterloo & Co (GMO)’s REX American Resources REX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20,292
Closed -$285K 824
2021
Q1
$285K Sell
20,292
-4,908
-19% -$75.4K ﹤0.01% 787
2020
Q4
$309K Hold
25,200
﹤0.01% 745
2020
Q3
$276K Sell
25,200
-9,000
-26% -$102K ﹤0.01% 702
2020
Q2
$395K Sell
34,200
-162,000
-83% -$1.61M ﹤0.01% 655
2020
Q1
$1.52M Sell
196,200
-66,000
-25% -$749K 0.01% 438
2019
Q4
$3.58M Sell
262,200
-39,600
-13% -$548K 0.02% 331
2019
Q3
$3.84M Buy
301,800
+101,400
+51% +$1.25M 0.03% 335
2019
Q2
$2.44M Buy
200,400
+124,200
+163% +$1.63M 0.02% 419
2019
Q1
$1.02M Buy
76,200
+19,200
+34% +$243K 0.01% 481
2018
Q4
$647K Buy
57,000
+36,600
+179% +$429K 0.01% 404
2018
Q3
$257K Buy
+20,400
New +$260K ﹤0.01% 497
2016
Q4
Sell
-14,394
Closed -$203K 539
2016
Q3
$203K Buy
+14,394
New +$175K ﹤0.01% 477

Other funds holding REX

Grantham, Mayo, Van Otterloo & Co (GMO)'s REX Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of REX American Resources (REX) in Q2 2021, closing a stake of 20,292 shares — an estimated $285K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in REX in Q3 2016 and held it in 12 quarters. The position peaked at $3.84M in Q3 2019. 116 funds tracked by Wall St. Rank hold REX as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining REX American Resources position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 20,292 REX American Resources shares in Q2 2021, an estimated $285K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in REX American Resources in Q3 2016 and held it in 12 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s REX American Resources position peaked at $3.84M in Q3 2019.
  • 116 funds tracked by Wall St. Rank held REX American Resources as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.